SMi are delighted to welcome the expertise from a senior panel of big biotech's and pharma organisations, as well as regulatory bodies, at the inaugural Cell & Gene Therapy 2018 conference ...

55 years ago today, the Nuclear Non-Proliferation Treaty went into effect after ratification by 43 nations agreeing to prevent the spread of nuclear weapons.

("Devonian" or the "Company") (TSXV: GSD; OTCQB: DVHGF), a clinical stage corporation focused on developing unique solutions to inflammatory diseases, today announced positive results from a gene ...

Primary Hyperoxaluria (PH) is a rare autosomal recessive genetic disorder caused by enzyme deficiencies in hepatic oxalate metabolism, leading to excessive oxalate production and systemic oxalate ...

Solid Biosciences’ gene therapy uses a shortened version of the dystrophin protein, which is engineered to mimic the key functions of full-length dystrophin and allows it be delivered more effectively ...

(NASDAQ: NASDAQ:RARE), a $4.08 billion market cap biotechnology company with 27% revenue growth in the past year, today unveiled new data indicating that its experimental gene therapy, UX111 ...

The filing reflects substantial data from the company’s ongoing Phase 1/2 clinical trial investigating the potential benefits of their gene therapy. This recent clinical study focuses on the ...

Because some genetic tests are screening tests, some (e.g., the multiple marker blood test) will generate some false-positive and false-negative results. The purpose of multiple marker screening ...

Gene regulation refers to the mechanisms that act to induce or repress the expression of a gene. These include structural and chemical changes to the genetic material, binding of proteins to ...

A genetic condition is one that happens when a gene changes. Some genetic conditions can be inherited (passed from parents to their children). Genes are sections of DNA (deoxyribonucleic acid) that ...